Do not exceed daily dose unless instructed by a healthcare practitioner
Checking your browser Please wait This quick check helps us filter automated traffic
The key principle is achieving gradual, sustained weight loss rather than rapid reduction
[4] OSA Coverage Requirements Sleep study documenting AHI 15 that's your apnea-hypopnea index, the number of breathing interruptions per hour of sleep BMI 30 No step therapy requirement for OSA indication (this is keymay bypass phentermine/Saxenda trial) Same contraindications apply (medullary thyroid cancer, pancreatitis, etc.) Why This Matters If you have diagnosed moderate-severe sleep apnea, you may qualify for Zepbound without needing to fail other weight loss drugs first
Intramyocellular lipid deposition, common in obesity but also a feature of sarcopenia, may result in part from mitochondrial dysfunction with resultant accumulation of unmetabolised free fatty acids [53]
Side effects can include nausea, reduced appetite, and mild injection site reactions
